Cesare Gridelli

19.5k citations
413 papers · 12.7k · 4 hit papers · h-index 55

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 258
    • Lung Cancer Diagnosis and Treatment 85
    • Lung Cancer Research Studies 146
    • Colorectal Cancer Treatments and Studies 51
    • Cancer Immunotherapy and Biomarkers 36
    • Cancer Treatment and Pharmacology 28

Cesare Gridelli

407 papers receiving 12.4k citations

Cesare Gridelli's Hit Papers

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial 2017 · 417 citations
4170+4+9Years since publication250500750

Peers

Cesare Gridelli
Comparison fields: 5 of 141
  • Oncology 5.4k
  • Pulmonary and Respiratory Medicine 5.7k
  • Cancer Research 1.2k
  • Geriatrics and Gerontology 239
  • Molecular Biology 2.5k
Replace Kathy S. Albain with:
Kathy S. Albain United States
Jee Hyun Kim South Korea
Silvia Novello Italy
Corinne Faivre‐Finn United Kingdom
Eitan Amir Canada
Massimo Di Maïo Italy
Nobuyuki Yamamoto Japan
Primo N. Lara United States
Stefan Sleijfer Netherlands
Anne‐Marie C. Dingemans Netherlands
Cesare Gridelli relative to Kathy S. Albain United States Kathy S. Albain's profile →
Citations per field
00.5×1.5×
Kathy S. Albain · 1×
Citations per year

Countries citing papers authored by Cesare Gridelli

Since Specialization
Citations

This map shows the geographic impact of Cesare Gridelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesare Gridelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesare Gridelli more than expected).

Fields of papers citing papers by Cesare Gridelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesare Gridelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesare Gridelli. The network helps show where Cesare Gridelli may publish in the future.

Co-authors

The 25 scholars most cited alongside Cesare Gridelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cesare Gridelli Line = papers co-authored together Cesare Gridelli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 413 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2012794
2
Non-small-cell lung cancer
Hit paper breakdown →
2015778
3
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
2017417
4 2012391
5 2005353
6
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
Hit paper breakdown →
2015338
7 1998243
8 2004225
9 2005181
10 2001173
11 2013146
12 2009144
13 2004143
14 2015126
15 2011125
16 2014123
17 2004122
18 1997122
19 2015121
20 2007116

About Cesare Gridelli

Cesare Gridelli is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 413 papers that have together received 12.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (258 papers), Lung Cancer Research Studies (146 papers), Lung Cancer Diagnosis and Treatment (85 papers), Colorectal Cancer Treatments and Studies (51 papers), Cancer Immunotherapy and Biomarkers (36 papers), Cancer therapeutics and mechanisms (35 papers), Cancer Treatment and Pharmacology (28 papers) and Cancer Genomics and Diagnostics (26 papers). The work is most often cited by research in Oncology (5.4k citations), Pulmonary and Respiratory Medicine (5.7k citations), Cancer Research (1.2k citations), Geriatrics and Gerontology (239 citations) and Molecular Biology (2.5k citations). Cesare Gridelli has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Antônio Rossi, Paolo Maione, Massimo Di Maïo, Enriqueta Felip, Fortunato Ciardiello, Solange Peters, Filippo de Marinis, Ciro Gallo, Francesco Perrone and Alex A. Adjei. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Clinical Oncology, Clinical Lung Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact